Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06558461
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-14
Brief Title:
Nebulised 3 Hypertonic Saline in Infants With Acute Bronchiolitis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Evaluating the Efficacy of Nebulised 3 Hypertonic Saline for Acute Bronchiolitis in Infants A Study at Can Tho Childrens Hospital 2022-2024
Status:
COMPLETED
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study aims to determine the efficacy of nebulising 3 hypertonic saline in improving clinical symptoms and reducing the length of hospital stay in infants with acute bronchiolitis
Detailed Description:
Bronchiolitis is the most prevalent disease in infants especially children younger than two years old Clinical manifestations vary from mild to severe even life-threatening respiratory failure Airway oedema and mucus plugging are the principal pathological features in infants with acute bronchiolitis Nebulising 3 hypertonic saline solution may reduce these pathological changes but the evidence remains equivocal
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None